MDGL - MADRIGAL PHARMACEUTICALS, INC.
439.34
4.540 1.033%
Share volume: 275,372
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$434.80
4.54
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-07-2024 | 10-31-2024 | 02-26-2025 | 05-01-2025 | 08-05-2025 | 11-04-2025 | 02-19-2026 | |
| Assets | |||||||||
| Total Assets | 1.082 B | 1.100 B | 1.073 B | 1.042 B | 996.629 M | 1.015 B | 1.362 B | 1.260 B | |
| Current Assets | 1.074 B | 1.092 B | 1.064 B | 1.033 B | 987.979 M | 1.003 B | 1.347 B | 1.246 B | |
| Inventories | 854.000 K | 7.072 M | 8.715 M | 34.068 M | 55.241 M | 63.497 M | 69.317 M | 74.841 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 436.546 M | 563.197 M | 765.943 M | 826.232 M | 659.422 M | 610.831 M | 814.055 M | 784.866 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 622.517 M | 494.597 M | 232.684 M | 100.019 M | 183.646 M | 186.193 M | 295.694 M | 198.693 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.742 M | 1.695 M | 2.268 M | 2.190 M | 1.901 M | 1.615 M | 2.913 M | 1.499 M | |
| Other Assets | 6.586 M | 6.366 M | 7.331 M | 7.130 M | 6.749 M | 10.410 M | 12.864 M | 12.320 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.082 B | 1.100 B | 1.073 B | 1.042 B | 996.629 M | 1.015 B | 1.362 B | 1.260 B | |
| Total liabilities | 231.521 M | 242.669 M | 296.110 M | 287.864 M | 285.992 M | 319.403 M | 736.725 M | 656.900 M | |
| Total current liabilities | 114.341 M | 125.162 M | 177.847 M | 169.277 M | 167.237 M | 196.503 M | 391.406 M | 310.288 M | |
| Accounts Payable | 21.528 M | 8.994 M | 45.966 M | 43.599 M | 42.056 M | 37.975 M | 44.941 M | 48.878 M | |
| Other liabilities | 1.045 M | 900.000 K | 1.176 M | 1.018 M | 750.000 K | 4.524 M | 5.566 M | 6.731 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 116.135 M | 116.607 M | 117.087 M | 117.569 M | 118.005 M | 118.376 M | 339.753 M | 339.881 M | |
| Other liabilities | 1.045 M | 900.000 K | 1.176 M | 1.018 M | 750.000 K | 4.524 M | 5.566 M | 6.731 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 850.759 M | 857.120 M | 777.155 M | 754.383 M | 710.637 M | 695.978 M | 625.732 M | 602.689 M | |
| Common stock | 2.335 B | 2.493 B | 2.519 B | 2.556 B | 2.586 B | 2.613 B | 2.657 B | 2.692 B | |
| Retained earnings | -1.484 B | -1.636 B | -1.743 B | -1.802 B | -1.875 B | -1.918 B | -2.032 B | -2.090 B |